American Century Companies’s Caris Life Sciences CAI Stock Holding History

American Century Companies’s Portfolio CAI Stock Details CAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$764K	Buy	42,899 +27,959	+187%	+$500K	﹤0.01%	2485
2026 Q1	$267K	Buy	+14,940	New	+$327K	﹤0.01%	2658
2025 Q4	–	Sell	-6,865	Closed	-$208K	–	2901
2025 Q3	$208K	Buy	+6,865	New	+$219K	﹤0.01%	2692

Other funds holding CAI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHWEPV

J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies's CAI Position: Q2 2026 in Review

American Century Companies increased its Caris Life Sciences (CAI) stake by 187% in Q2 2026, buying an estimated $500K and bringing the position to 42,899 shares worth $764K. The position accounts for ﹤0.01% of the portfolio, ranked #2485.

American Century Companies first reported a position in CAI in Q3 2025 and has held it in 3 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

American Century Companies held 42,899 shares of Caris Life Sciences worth $764K as of Q2 2026.
American Century Companies bought 27,959 Caris Life Sciences shares in Q2 2026, an estimated $500K.
Caris Life Sciences made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2485 holding.
American Century Companies first reported a position in Caris Life Sciences in Q3 2025 and has held it in 3 quarters since.
247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.